These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 22554644
1. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, Quinn HE, Menzies R, McIntyre P. Vaccine; 2012 Jun 08; 30(27):4073-8. PubMed ID: 22554644 [Abstract] [Full Text] [Related]
2. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore. Chua YX, Ang LW, Low C, James L, Cutter JL, Goh KT. Vaccine; 2015 Jun 17; 33(27):3150-7. PubMed ID: 25887085 [Abstract] [Full Text] [Related]
3. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012. Chan J, Dey A, Wang H, Martin N, Beard F. Commun Dis Intell Q Rep; 2015 Mar 31; 39(1):E19-26. PubMed ID: 26063094 [Abstract] [Full Text] [Related]
4. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia. Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, MacIntyre CR. Vaccine; 2013 Jan 11; 31(4):691-7. PubMed ID: 23196206 [Abstract] [Full Text] [Related]
5. Australian rubella serosurvey 2012-2013: On track for elimination? Edirisuriya C, Beard FH, Hendry AJ, Dey A, Gidding HF, Hueston L, Dwyer DE, Wood JG, Macartney KK, McIntyre PB. Vaccine; 2018 May 11; 36(20):2794-2798. PubMed ID: 29661586 [Abstract] [Full Text] [Related]
6. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C. Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126 [Abstract] [Full Text] [Related]
7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K, Nicoara C, Germann D, Matter L. Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837 [Abstract] [Full Text] [Related]
8. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile. Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P. Eur J Public Health; 2012 Feb 25; 22(1):133-9. PubMed ID: 20880991 [Abstract] [Full Text] [Related]
9. Rubella seropositivity in the United States, 1988-1994. Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, Forghani B, Hadler SC. Clin Infect Dis; 2001 Oct 15; 33(8):1279-86. PubMed ID: 11565065 [Abstract] [Full Text] [Related]
10. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Sullivan EM, Burgess MA, Forrest JM. Commun Dis Intell; 1999 Aug 05; 23(8):209-14. PubMed ID: 10497832 [Abstract] [Full Text] [Related]
11. Surveillance and vaccination coverage of measles and rubella in Northern Italy. Amendola A, Bubba L, Piralla A, Binda S, Zanetti A, Pariani E, Ranghiero A, Premoli M, Pellegrinelli L, Coppola L, Gramegna M, Baldanti F, Zanetti A. Hum Vaccin Immunother; 2015 Aug 05; 11(1):206-13. PubMed ID: 25483537 [Abstract] [Full Text] [Related]
12. Toward rubella elimination in Europe: an epidemiological assessment. Muscat M, Zimmerman L, Bacci S, Bang H, Glismann S, Mølbak K, Reef S, EUVAC.NET group. Vaccine; 2012 Mar 02; 30(11):1999-2007. PubMed ID: 22178098 [Abstract] [Full Text] [Related]
13. Progress toward measles and rubella elimination in Egypt. El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE. J Infect Dis; 2011 Jul 02; 204 Suppl 1():S318-24. PubMed ID: 21666180 [Abstract] [Full Text] [Related]
14. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF. Vaccine; 2013 Dec 17; 32(1):69-73. PubMed ID: 24188751 [Abstract] [Full Text] [Related]
15. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine. Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C. Vaccine; 2012 Dec 14; 30(52):7506-12. PubMed ID: 23103194 [Abstract] [Full Text] [Related]
16. [Rubella epidemiology in Italy in years 1998-2004]. Giambi C, Rota MC, Bella A, Filia A, Gabutti G, Guido M, De Donno A, Ciofi degli Atti ML. Ann Ig; 2007 Dec 14; 19(2):93-102. PubMed ID: 17547214 [Abstract] [Full Text] [Related]
17. Rubella elimination programme strengthened through measles elimination programme in Catalonia. Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L. Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357 [Abstract] [Full Text] [Related]
18. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 Feb 27; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
19. Sustained measles elimination in Australia and priorities for long term maintenance. Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, McIntyre PB. Vaccine; 2007 May 04; 25(18):3574-80. PubMed ID: 17300858 [Abstract] [Full Text] [Related]
20. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008. Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269 [Abstract] [Full Text] [Related] Page: [Next] [New Search]